1 domain / 2 areas / 1 specialization
Jefferies
Data updated
Jefferies is a global full-service investment banking and capital markets firm, rather than a specialist psychedelic investor. Its public materials describe the firm as operating worldwide, with principal offices in New York and regional headquarters in London and Hong Kong.
In the psychedelic ecosystem, Jefferies matters mainly as a broad capital-markets and research platform that has published industry thought leadership on psychedelics and mental health. Its public primer on mental health and psychedelics notes active investor interest in the space and discusses public and private psychedelic drug-development companies, but it does not establish Jefferies as a dedicated psychedelic-focused fund.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
Jefferies is best characterized as a global investment banking and capital markets platform with healthcare and biotech coverage, not a standalone psychedelic specialist. Its public content shows awareness of psychedelics as an emerging sector and references investor activity across drug development, clinics, infrastructure, and related services, which may make it relevant as an advisor, market connector, or thematic research source rather than a direct psychedelic capital allocator.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 1962
- HQ
- 520 Madison Avenue, New York, NY 10022, United States
- Website
- Visit